Literature DB >> 11585721

Plasmids with a mammalian replication origin and a matrix attachment region initiate the event similar to gene amplification.

N Shimizu1, Y Miura, Y Sakamoto, K Tsutsui.   

Abstract

Gene amplification plays a crucial role in the development of many human malignancies. Amplified genes are frequently localized on double minutes (DMs). We show here that plasmids bearing both a mammalian replication origin and a nuclear matrix attachment region were able to integrate into DMs if transfected to cells having DMs (COLO 320DM). Furthermore, these plasmids triggered the events leading to the de novo formation of the structure similar to DMs if transfected to the cells without DMs (COLO 320HSR or HeLa). Autonomous replication of these plasmids was suggested to be a prerequisite for these events to occur, because the presence of the origin sequences in the plasmids was required. The presence of matrix attachment region in the plasmids is also required for these events to occur, suggesting that matrix attachment plays an indispensable role in extrachromosomal replication. This model system will allow us to investigate the mechanism of gene amplification as well as to analyze the autonomous replication of the plasmid with mammalian replication origins.

Entities:  

Mesh:

Year:  2001        PMID: 11585721

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  28 in total

1.  A hyper-dynamic equilibrium between promoter-bound and nucleoplasmic dimers controls NF-kappaB-dependent gene activity.

Authors:  Daniela Bosisio; Ivan Marazzi; Alessandra Agresti; Noriaki Shimizu; Marco E Bianchi; Gioacchino Natoli
Journal:  EMBO J       Date:  2006-02-09       Impact factor: 11.598

2.  Simulated body temperature rhythms reveal the phase-shifting behavior and plasticity of mammalian circadian oscillators.

Authors:  Camille Saini; Jörg Morf; Markus Stratmann; Pascal Gos; Ueli Schibler
Journal:  Genes Dev       Date:  2012-02-29       Impact factor: 11.361

3.  How transcription proceeds in a large artificial heterochromatin in human cells.

Authors:  Koh-ichi Utani; Noriaki Shimizu
Journal:  Nucleic Acids Res       Date:  2008-11-29       Impact factor: 16.971

4.  Episomal high copy number maintenance of hairpin-capped DNA bearing a replication initiation region in human cells.

Authors:  Seiyu Harada; Masafumi Uchida; Noriaki Shimizu
Journal:  J Biol Chem       Date:  2009-07-18       Impact factor: 5.157

5.  Restriction to Fos family members of Trip6-dependent coactivation and glucocorticoid receptor-dependent trans-repression of activator protein-1.

Authors:  Markus Diefenbacher; Sylwia Sekula; Christine Heilbock; Jana V Maier; Margarethe Litfin; Hans van Dam; Marc Castellazzi; Peter Herrlich; Olivier Kassel
Journal:  Mol Endocrinol       Date:  2008-06-05

Review 6.  The contributions of extrachromosomal DNA elements in neoplasm progression.

Authors:  Jiawei Hong; Shusen Zheng; Donghai Jiang
Journal:  Am J Cancer Res       Date:  2021-06-15       Impact factor: 6.166

7.  Amplification of a plasmid bearing a mammalian replication initiation region in chromosomal and extrachromosomal contexts.

Authors:  Seiyu Harada; Naoki Sekiguchi; Noriaki Shimizu
Journal:  Nucleic Acids Res       Date:  2010-10-06       Impact factor: 16.971

8.  Generation of micronuclei during interphase by coupling between cytoplasmic membrane blebbing and nuclear budding.

Authors:  Koh-ichi Utani; Atsushi Okamoto; Noriaki Shimizu
Journal:  PLoS One       Date:  2011-11-02       Impact factor: 3.240

9.  Efficient recombinant production in mammalian cells using a novel IR/MAR gene amplification method.

Authors:  Yoshio Araki; Tetsuro Hamafuji; Chiemi Noguchi; Noriaki Shimizu
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

10.  Fusion of the Dhfr/Mtx and IR/MAR gene amplification methods produces a rapid and efficient method for stable recombinant protein production.

Authors:  Chiemi Noguchi; Yoshio Araki; Daisuke Miki; Noriaki Shimizu
Journal:  PLoS One       Date:  2012-12-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.